CD34+ cell dose predicts survival, posttransplant...

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies: Mavroudis D, Read E, Cottler-Fox M, et al. Blood 88:3223–3229, 1996

How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
1997
Language:
english
DOI:
10.1016/s0887-7963(97)80081-8
File:
PDF, 123 KB
english, 1997
Conversion to is in progress
Conversion to is failed